Managing International Bio-Risk
| Date | Friday, October 26, 2007 |
| Location | Senate Capitol, Room SC 6 |
Dr. Julie Fischer, director of the Global Health Security Program at the Henry L. Stimson Center, will join us for a discussion on the risks and regulation of the rapidly expanding global biodefense enterprise. Concerns about possible bioterrorism and emerging infectious diseases like SARS and avian influenza have convinced policymakers worldwide to invest in the infrastructure necessary to detect and limit potentially catastrophic outbreaks. The resulting rapid expansion of laboratory capacity and research programs provides the backbone of a real global disease surveillance capability, but also increases the risk that lethal pathogens could be accidentally or deliberately released. What is the U.S. investment in promoting biological security and safety abroad, and how has the international community approached the management of bio-risk?